Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
35 hedge funds and large institutions have $47.1M invested in Global Cord Blood Corporation in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 8 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
12% more capital invested
Capital invested by funds: $42M → $47.1M (+$5.18M)
3% less funds holding
Funds holding: 36 → 35 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GP
GLG Partners
London,
United Kingdom
|
+$3.55M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.5M |
| 3 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$688K |
| 4 |
Renaissance Technologies
New York
|
+$624K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$399K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.44M |
| 2 |
SG Americas Securities
New York
|
-$869K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$602K |
| 4 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$597K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$589K |
CO Hedge Fund Activity: Q4 2015 in Review
35 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2015, worth a combined $47.1M — up 12% from $42M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CO and 7 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 13 added.
The largest buyer was GLG Partners, adding an estimated $3.55M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $2.44M sold.
- 35 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2015, down from 36 in Q3 2015.
- Funds reported $47.1M of Global Cord Blood Corporation stock for Q4 2015, up 12% quarter-over-quarter.
- 7 funds opened new Global Cord Blood Corporation positions in Q4 2015 and 8 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation buyer in Q4 2015 was GLG Partners, an estimated $3.55M added.
- The largest Global Cord Blood Corporation seller in Q4 2015 was Farallon Capital Management, an estimated $2.44M sold.
Based on aggregated 13F filings for Q4 2015.